68 results on '"de‐Torres, Juan P."'
Search Results
2. Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
3. “Another Hole in the Wall”
4. Physiological underpinnings of exertional dyspnoea in mild fibrosing interstitial lung disease
5. New or enlarging hiatal hernias after thoracic surgery for early lung cancer
6. Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
7. Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
8. The importance of low-dose CT screening to identify emphysema in asymptomatic participants with and without a prior diagnosis of COPD
9. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD
10. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD
11. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
12. Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients
13. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
14. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort
15. Lung Function Testing in Chronic Obstructive Pulmonary Disease
16. Sex differences between women and men with COPD: A new analysis of the 3CIA study
17. Interstitial Lung Abnormalities and Lung Cancer Risk in the National Lung Screening Trial
18. Prognostic Validation Using GesEPOC 2017 Severity Criteria
19. Validación pronóstica según los criterios de la GesEPOC 2017
20. Survival with Parenchymal and Pleural Invasion of Non–Small Cell Lung Cancers Less than 30 mm
21. Temporal transitions in COPD severity stages within the GOLD 2017 classification system
22. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD
23. Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease
24. Documento de expertos del uso de broncodilatadores inhalados en monoterapia en el tratamiento de la EPOC estable leve-moderada
25. Expert Statement on the Single-Agent Use of Inhaled Bronchodilator in the Treatment of Stable Mild-Moderate Chronic Obstructive Pulmonary Disease
26. Is Chronic Obstructive Pulmonary Disease Really a Progressive Disease?
27. ¿Es realmente la enfermedad pulmonar obstructiva crónica una enfermedad progresiva?
28. Differences Between GesEPOC and GOLD in 2017
29. Diferencias entre GesEPOC y GOLD en el año 2017
30. Enfermedad pulmonar obstructiva crónica en mujeres: ¿somos diferentes?
31. Chronic Obstructive Pulmonary Disease in Women. Is it Different?
32. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation
33. Lung Cancer and Emphysema
34. Cáncer de pulmón y enfisema
35. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT
36. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development
37. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO
38. Simplifying the Guidelines: The 10 COPD Commandments
39. Simplificando las guías: los 10 mandamientos de la EPOC
40. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort
41. Efectos inmunomoduladores del glatirámero acetato y su potencial papel en la reactivación de la tuberculosis pulmonar
42. Immunomodulating Effects of Glatiramer Acetate and Its Potential Role in Pulmonary Tuberculosis Reactivation
43. El índice BODE: un buen marcador de calidad de vida en pacientes con enfermedad pulmonar obstructiva crónica
44. BODE Index: A Good Quality of Life Marker in Chronic Obstructive Pulmonary Disease Patients
45. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD
46. Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data
47. Cribado de cáncer de pulmón: catorce años de experiencia del Programa Internacional de Detección Precoz de Cáncer de Pulmón con TBDR de Pamplona (P-IELCAP)
48. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)
49. Clinical Application of the COPD Assessment Test
50. Response to “Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients”
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.